Shares of AbbVie were getting hammered Monday after the drug maker said two Phase 2 trials of its experimental schizophrenia ...

the top eight teams in the table at the end of the league phase earn automatic berths into the knockout phase. This leaves ...

Phase 2 studies for emraclidine failed to show a statistically significant improvement in symptoms after six weeks, the biopharmaceutical company said Monday. The North Chicago, Ill. company said it ...